eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
1/2021
vol. 72
 
Share:
Share:
more
 
 
abstract:
Original paper

Immunohistochemical expression analysis of MMP-1, TIMP-2 and p53 in Barrett’s esophagus, dysplasia and esophageal adenocarcinoma

Alejandro García-Varona
1
,
Iván Fernández-Vega
2
,
Jorge Santos-Juanes
3

1.
Department of Pathology, Hospital El Bierzo, Ponferrada, Spain
2.
Department of Pathology, Hospital Universitario Central de Asturias, Oviedo, Spain
3.
Department of Dermatology, Hospital Universitario Central de Asturias, Oviedo, Spain
Pol J Pathol 2021; 72 (1): 48-56
Online publish date: 2021/05/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Barrett’s esophagus (BE) is the most important risk factor for the development of esophageal adenocarcinoma. It develops through a progressive sequence of histologic and molecular events that begin with metaplasia and then progresses through various stages of dysplasia. Matrix metalloproteinases are involved in the degradation of the extracellular matrix and play an important role in tumor progression.

The immunohistochemical expression of MMP-1, TIMP-2 and p53 in 111 samples from 45 patients diagnosed with BE with and without dysplasia and adenocarcinoma of the esophagus was retrospectively studied, and statistical analysis was conducted to measure the association between their expression and the degree of dysplasia present.

MMP-1 was expressed in 33.3% of the samples studied, mainly in the adenocarcinoma subgroup with up to 40% positive cases (p = 0.494). In contrast, TIMP-2 was expressed in 25.2% of the samples, and no positive cases were identified in the adenocarcinoma subgroup (p = 0.037). Aberrant p53 expression was observed in 81.4% of the samples diagnosed with some degree of dysplasia (p < 0.001).

MMP-1 showed no statistically significant differences between diagnostic entities. A statistically significant loss of TIMP-2 expression was observed in distal esophageal adenocarcinoma samples, which contrasts with the aberrant expression of p53 in dysplastic cases.
keywords:

Barrett’s esophagus, esophageal adenocarcinoma, matrix metalloproteinases, p53, immunohistochemistry

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe